NSE - Delayed Quote INR
Zydus Lifesciences Limited (ZYDUSLIFE.NS)
859.65
-20.60
(-2.34%)
At close: April 25 at 3:30:00 PM GMT+5:30
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Operating Cash Flow
--
32,279,000
26,888,000
21,045,000
32,939,000
Investing Cash Flow
--
-14,752,000
15,350,000
-10,003,000
-7,246,000
Financing Cash Flow
--
-18,104,000
-44,004,000
-8,683,000
-25,477,000
End Cash Position
--
4,130,000
4,878,000
11,069,000
10,872,000
Capital Expenditure
--
-9,066,000
-10,309,000
-12,026,000
-8,540,000
Issuance of Capital Stock
--
--
--
--
9,866,000
Issuance of Debt
--
--
1,552,000
7,464,000
--
Repayment of Debt
--
-827,000
-9,960,000
-14,208,000
-25,683,000
Repurchase of Capital Stock
--
-7,250,000
-8,632,000
--
--
Free Cash Flow
--
23,213,000
16,579,000
9,019,000
24,399,000
3/31/2021 - 4/27/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
DRREDDY.NS Dr. Reddy's Laboratories Limited
1,174.80
-2.14%
CIPLA.NS Cipla Limited
1,525.90
-1.66%
NATCOPHARM.NS NATCO Pharma Limited
889.25
-1.51%
GLENMARK.NS Glenmark Pharmaceuticals Limited
1,360.70
-4.24%
SUNPHARMA.NS Sun Pharmaceutical Industries Limited
1,787.40
-0.91%
TORNTPHARM.NS Torrent Pharmaceuticals Limited
3,238.90
-2.59%
LAURUSLABS.NS Laurus Labs Limited
625.65
-3.08%
AUROPHARMA.NS Aurobindo Pharma Limited
1,220.10
-3.00%
MANKIND.NS Mankind Pharma Limited
2,557.50
-1.60%
NATCOPHARM.BO NATCO Pharma Limited
889.65
-1.55%